Pharma and Biotech
No deals were found in the last 365 days.
No deals were found in the last 365 days.
No director shareholdings found for this company
| Notifier** | Holding | Value* |
|---|---|---|
| Mark H Dixon and Diana Dixon | 76,000,000 | £4,149,189 |
| Mark H Dixon | 50,000,000 | £2,729,730 |
| David Campbell Brierwood | 16,416,813 | £896,269 |
| Tyndall Investment Management | 13,165,553 | £718,768 |
| Tyndall Investment Management | 13,165,553 | £718,768 |
| Seneca Partners Limited | 10,561,405 | £576,596 |
| Unicorn Asset Management Limited | 7,894,736 | £431,010 |
| Andrew McBain | 4,301,433 | £234,835 |
| Currency | UK Pounds |
| Share Price | 5.46p |
| Change Today | -0.29p |
| % Change | -5.05 % |
| 52 Week High | 5.75 |
| 52 Week Low | 5.46 |
| Volume | 135,388 |
| Shares Issued | 259.04m |
| Market Cap | £14.14m |
| Value |
|
|---|
| Price Trend | ![]() |
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 08:22 | 30,000 @ 5.50p |
| 08:22 | 30,000 @ 5.50p |
| 08:22 | 30,000 @ 5.50p |
| 08:21 | 9,110 @ 5.53p |
| 08:20 | 18,139 @ 5.54p |
You are here: research